Systematic Comparison of CRISPR and shRNA Screens to Identify Essential Genes Using a Graph-Based Unsupervised Learning Model.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 10 09 2024
revised: 28 09 2024
accepted: 01 10 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Generally, essential genes identified using shRNA and CRISPR are not always the same, raising questions about the choice between these two screening platforms. To address this, we systematically compared the performance of CRISPR and shRNA to identify essential genes across different gene expression levels in 254 cell lines. As both platforms have a notable false positive rate, to correct this confounding factor, we first developed a graph-based unsupervised machine learning model to predict common essential genes. Furthermore, to maintain the unique characteristics of individual cell lines, we intersect essential genes derived from the biological experiment with the predicted common essential genes. Finally, we employed statistical methods to compare the ability of these two screening platforms to identify essential genes that exhibit differential expression across various cell lines. Our analysis yielded several noteworthy findings: (1) shRNA outperforms CRISPR in the identification of lowly expressed essential genes; (2) both screening methodologies demonstrate strong performance in identifying highly expressed essential genes but with limited overlap, so we suggest using a combination of these two platforms for highly expressed essential genes; (3) notably, we did not observe a single gene that becomes universally essential across all cancer cell lines.

Identifiants

pubmed: 39404416
pii: cells13191653
doi: 10.3390/cells13191653
pii:
doi:

Substances chimiques

RNA, Small Interfering 0

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Natural Sciences and Engineering Research Council of Canada (NSERC),
ID : RGPIN-2021-03297

Auteurs

Yulian Ding (Y)

Central for High-Performance Computing, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Division of Biomedical Engineering, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada.
Cancer Research Department, Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada.

Connor Denomy (C)

Division of Oncology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Andrew Freywald (A)

Department of Pathology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Yi Pan (Y)

Central for High-Performance Computing, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Department of Computer Science and Control Engineering, Shenzhen University of Advanced Technology, Shenzhen 518055, China.

Franco J Vizeacoumar (FJ)

Cancer Research Department, Saskatchewan Cancer Agency, Saskatoon, SK S7N 5E5, Canada.
Division of Oncology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Frederick S Vizeacoumar (FS)

Department of Pathology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Fang-Xiang Wu (FX)

Division of Biomedical Engineering, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada.
Department of Mechanical Engineering, Department of Computer Science, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH